Spanish-Portuguese consensus statement on use of daylight-mediated photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis. [electronic resource]
Producer: 20170515Description: 623-31 p. digitalISSN:- 1578-2190
- Aminolevulinic Acid -- adverse effects
- Clinical Protocols
- Humans
- Keratosis, Actinic -- drug therapy
- Patient Selection
- Photochemotherapy -- adverse effects
- Photosensitizing Agents -- adverse effects
- Portugal
- Spain
- Sunlight -- adverse effects
- Sunscreening Agents -- therapeutic use
- Temperature
- Treatment Outcome
No physical items for this record
Publication Type: Consensus Development Conference; Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.